Laurie Barclay, MD
NEW YORK (MedscapeWire) May 01 Consensus guidelines for management of abnormal Papanicolaou (Pap) smears, developed at a conference sponsored by the American Society for Colposcopy and Cervical Pathology (ASCCP) on September 6-8, 2001, in Bethesda, Maryland, are summarized in the April 24 issue of The Journal of the American Medical Association.
"Women with atypical squamous cells (ASC) of undetermined significance (ASC-US) should be managed using a program of 2 repeat cytology tests, immediate colposcopy, or DNA testing for high-risk types of human papillomavirus (HPV)," write Thomas C. Wright Jr, MD, from Columbia University in New York, and colleagues. "Testing for HPV DNA is the preferred approach when liquid-based cytology is used for screening."
A panel of 121 experts in the diagnosis and management of cervical cancer precursors developed these guidelines using a multistep approach, including literature review and input from the professional community. They concluded that HPV testing has been clinically validated and can become integral to both screening and clinical management.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!